Ramin Fazel
Department of Biotechnology, College of science, The University of Tehran, Tehran, Iran.
[ 1 ] - Physicochemical Characterization of Altebrel™, a Proposed Etanercept Biosimilar
Background: Etanercept is prescribed for the rapid and effective treatment of chronic immune-mediated inflammatory disorders. Due to the expiration of etanercept patents and worldwide demand for comparable and more affordable substitutes, several biosimilars of etanercept have been approved in different countries and new ones are in the process of approval.Objectives: In the present study...
Co-Authors